Clinical Trial Update: Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in Patients With MCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining the effect of EGb 761(r) on blood markers of inflammation and oxidative stress in patients with Mild Cognitive Impairment (MCI)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• EGb 761(r)

Snippet

Sponsor: Fundació ACE Institut Català de Neurociències Aplicades | Conditions: Mild Cognitive Impairment (MCI) | Phase 4 | Status: UNKNOWN